Kidney Diseases  >>  pamrevlumab (FG-3019)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pamrevlumab (FG-3019) / FibroGen
NCT00913393: Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy

Terminated
2
46
US
FG-3019, Placebo
FibroGen
Type 2 Diabetes Mellitus, Diabetic Nephropathy, Diabetic Kidney Disease
06/10
06/10

Download Options